IMVT Operating Expenses
Immunovant Inc · Operating Expenses
IMVT Operating Expenses
Latest reported$566.00Mperiod ending
IMVT TTM Operating Expenses ($11.55M → $566.00M)
TTM operating expenses
High-resolution chart · PNG
IMVT operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 566,001,000 | |
| 532,902,000 | |
| 487,173,000 | |
| 487,113,000 | |
| 471,094,000 | |
| 438,151,000 | |
| 405,205,000 | |
| 352,456,000 | |
| 298,513,000 | |
| 270,209,000 | |
| 253,589,000 | |
| 246,063,000 | |
| 233,877,000 | |
| 208,275,000 | |
| 191,243,000 | |
| 178,487,000 | |
| 166,523,000 | |
| 156,034,000 | |
| 137,724,000 | |
| 128,093,000 | |
| 111,417,000 | |
| 108,117,000 | |
| 99,683,000 | |
| 79,084,000 | |
| 58,529,757 | |
| 32,036,099 | |
| 11,553,549 | |
| 9,353,981 | |
| 15,280,219 | |
| 19,556,261 |